WallStreetZenWallStreetZen

NASDAQ: DCTH
Delcath Systems Inc Stock Forecast, Predictions & Price Target

Analyst price target for DCTH

Based on 1 analyst offering 12 month price targets for Delcath Systems Inc.
Min Forecast
$20.00+310.68%
Avg Forecast
$20.00+310.68%
Max Forecast
$20.00+310.68%

Should I buy or sell DCTH stock?

Based on 1 analyst offering ratings for Delcath Systems Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their DCTH stock forecasts and price targets.

DCTH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-27

1 of 1

Forecast return on equity

Is DCTH forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
36%

Forecast return on assets

Is DCTH forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

DCTH revenue forecast

What is DCTH's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$27.0M+1,207.51%
Avg 2 year Forecast
$62.3M+2,916.95%
Avg 3 year Forecast
$119.3M+5,676.76%
DCTH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DCTH revenue growth forecast

How is DCTH forecast to perform vs Medical Devices companies and vs the US market?
Company
282.62%
Industry
8.29%
Market
10.06%
DCTH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DCTH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DCTH vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
DCTH$4.87$20.00+310.68%Buy
OM$2.32$5.83+151.42%Buy
TELA$4.75$13.67+187.73%Strong Buy
ELMD$14.50N/AN/A
XTNT$0.83$2.00+140.96%Strong Buy

Delcath Systems Stock Forecast FAQ

Is Delcath Systems Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: DCTH) stock is to Buy DCTH stock.

Out of 1 analyst, 0 (0%) are recommending DCTH as a Strong Buy, 1 (100%) are recommending DCTH as a Buy, 0 (0%) are recommending DCTH as a Hold, 0 (0%) are recommending DCTH as a Sell, and 0 (0%) are recommending DCTH as a Strong Sell.

If you're new to stock investing, here's how to buy Delcath Systems stock.

What is DCTH's revenue growth forecast for 2024-2026?

(NASDAQ: DCTH) Delcath Systems's forecast annual revenue growth rate of 282.62% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.29%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.06%.

Delcath Systems's revenue in 2024 is $2,065,000.On average, 1 Wall Street analysts forecast DCTH's revenue for 2024 to be $663,192,684, with the lowest DCTH revenue forecast at $663,192,684, and the highest DCTH revenue forecast at $663,192,684. On average, 1 Wall Street analysts forecast DCTH's revenue for 2025 to be $1,530,255,712, with the lowest DCTH revenue forecast at $1,530,255,712, and the highest DCTH revenue forecast at $1,530,255,712.

In 2026, DCTH is forecast to generate $2,930,083,529 in revenue, with the lowest revenue forecast at $2,930,083,529 and the highest revenue forecast at $2,930,083,529.

What is DCTH's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: DCTH) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of N/A.

What is DCTH's Price Target?

According to 1 Wall Street analyst that have issued a 1 year DCTH price target, the average DCTH price target is $20.00, with the highest DCTH stock price forecast at $20.00 and the lowest DCTH stock price forecast at $20.00.

The Wall Street analyst predicted that Delcath Systems's share price could reach $20.00 by Mar 27, 2025. The average Delcath Systems stock price prediction forecasts a potential upside of 310.68% from the current DCTH share price of $4.87.

What is DCTH's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: DCTH) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.